QuantaMatrix Inc. (317690.KQ)
KOSDAQ · KRW · Healthcare · Medical Devices
₩2,060 (-3.96%) as of
Key statistics
- Market cap
- 41.48B
- Dividend yield
- 0.00%
- 52-week range
- 1,927.00 – 5,660.00
- Beta
- 0.21
- Revenue (TTM)
- 3.15B
- Profit margin
- 0.00%
- Volume
- 38.32k
About QuantaMatrix Inc.
QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early diagnosis kit for Alzheimer's disease; and Quanti9 and QuantiGal, a prognostic prediction kit for cardiovascular diseases. QuantaMatrix Inc. was founded in 2010 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.